Specialty Pharma Journal Specialty, Precision & Technology
Vaccines to combat a virus that can lead to fatal lung infections are urgently needed to help prevent child deaths worldwide, research suggests. Experts report that more than 115,000 children under five are dying each year from complications associated with the infection, called Respiratory Syncytial Virus (RSV). Almost half of …
Tag Archives: Respiratory Syncytial Virus
July, 2017
April, 2015
-
9 April
MedImmune’s Respiratory Syncytial Virus Candidate Receives Fast Track Status from the FDA
Today, AstraZeneca’s biologics arm MedImmune announced that US health regulators have granted fast track designation for its respiratory syncytial virus (RSV) candidate. The company said that the US Food and Drug Administration (FDA) has granted Fast Track status for the development of MEDI8897, a high-potency, extended half-life monoclonal antibody (mAb). …